Skip to main content

Moderate-Dose Hydroxyurea for Primary Prevention of Strokes in Nigerian Children with Sickle Cell Disease: Final Results of the SPIN Trial


AUTHORS

Galadanci NA , Abdullahi SU , Abubakar SA , Wudil BJ , Aminu H , Tijjani A , Abba MS , Tabari MA , Galadanci A , Borodo A , Belonwu R , Salihu AS , Rodeghier M , Ghafuri DL , Covert Greene BV , Neville K , Kassim AA , Kirkham F , Jordan LC , Aliyu MH , DeBaun MR , . American journal of hematology. 2020 6 8; ().

ABSTRACT



Tags: